|
| Status |
Public on Aug 21, 2024 |
| Title |
Tissue sample from mRCC patient with ICB treatment RCC1 |
| Sample type |
RNA |
| |
|
| Source name |
Renal Cell Carcinoma - Tumor
|
| Organism |
Homo sapiens |
| Characteristics |
condition: mRCC
|
| Extracted molecule |
total RNA |
| Extraction protocol |
The samples was extracted from FFPE samples using Norgen RNA/DNA purification kit
|
| Label |
No Labelling
|
| Label protocol |
n/a
|
| |
|
| Hybridization protocol |
n/a
|
| Scan protocol |
nCounter Analysis Platform
|
| Description |
Tissue sample from mRCC patient with ICB treatment
total RNA from mRCC was extracted from FFPE and profiled with Nanostring PanCancer IO360 Panel
|
| Data processing |
nCounter Analysis Platform
|
| |
|
| Submission date |
Aug 21, 2024 |
| Last update date |
Aug 21, 2024 |
| Contact name |
Abner Lim |
| E-mail(s) |
abner.lim.m.s@nccs.com.sg
|
| Organization name |
National Cancer Center Singapore
|
| Department |
Division of Medical Oncology
|
| Lab |
Cancer Discovery Hub
|
| Street address |
30 Hospital Boulevard
|
| City |
Singapore |
| ZIP/Postal code |
168583 |
| Country |
Singapore |
| |
|
| Platform ID |
GPL32069 |
| Series (1) |
| GSE275422 |
Aristolochic acid-related renal cell carcinoma exhibits a distinct tumor immune microenvironment and may be more responsive to immune checkpoint blockade |
|
